Haleon PLC Discloses Executive Shareholding Details

Haleon PLC ( (GB:HLN) ) has provided an announcement.

Haleon PLC announced a notification regarding the shareholding of Ed Petter, Chief Corporate Affairs Officer, who received the first tranche of Haleon Ordinary Shares under the company’s Share Value Plan. This award was part of his remuneration package to compensate for incentives forfeited from his previous employment, and it is subject to malus and clawback provisions. This transaction reflects Haleon’s adherence to UK Market Abuse Regulations and highlights the company’s commitment to transparent executive compensation practices.

The most recent analyst rating on (GB:HLN) stock is a Hold with a £340.00 price target. To see the full list of analyst forecasts on Haleon PLC stock, see the GB:HLN Stock Forecast page.

Spark’s Take on GB:HLN Stock

According to Spark, TipRanks’ AI Analyst, GB:HLN is a Outperform.

Haleon PLC demonstrates solid financial performance and a strong strategic direction, particularly through its earnings call and corporate events. The technical analysis suggests positive momentum, though valuation metrics indicate potential overvaluation. The company’s proactive capital management and confidence in growth prospects support a favorable outlook.

To see Spark’s full report on GB:HLN stock, click here.

More about Haleon PLC

Haleon PLC is a global leader in consumer health, focusing on delivering better everyday health with humanity. The company’s product portfolio includes Oral Health, Vitamins, Minerals and Supplements, Pain Relief, Respiratory Health, Digestive Health, and Therapeutic Skin Health, featuring well-known brands like Advil, Centrum, Otrivin, Panadol, parodontax, Polident, Sensodyne, Theraflu, and Voltaren.

Average Trading Volume: 27,563,473

Technical Sentiment Signal: Buy

Current Market Cap: £37.3B

Find detailed analytics on HLN stock on TipRanks’ Stock Analysis page.